Tenet Healthcare (NYSE:THC – Free Report) had its price target raised by UBS Group from $137.00 to $150.00 in a research report report published on Wednesday, Benzinga reports. The firm currently has a buy rating on the stock. Other research analysts have also issued reports about the stock. Deutsche Bank Aktiengesellschaft upped their price objective […]
Truist Financial reaffirmed their buy rating on shares of Tenet Healthcare (NYSE:THC – Free Report) in a report published on Wednesday, Benzinga reports. They currently have a $130.00 target price on the stock, up from their prior target price of $120.00. A number of other brokerages also recently commented on THC. Wells Fargo & Company […]
Tenet Healthcare (NYSE:THC – Free Report) had its target price lifted by Royal Bank of Canada from $109.00 to $136.00 in a report released on Wednesday morning, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock. THC has been the subject of a number of other reports. UBS Group upped […]
Tenet Healthcare (NYSE:THC – Free Report) had its price target increased by Royal Bank of Canada from $109.00 to $136.00 in a report released on Wednesday, Benzinga reports. They currently have an outperform rating on the stock. THC has been the topic of a number of other research reports. UBS Group boosted their price objective […]
Tenet Healthcare (NYSE:THC – Get Free Report) had its target price lifted by investment analysts at Barclays from $113.00 to $147.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Barclays‘s price objective indicates a potential upside of 22.21% from the stock’s current […]